Global Point of Care (POC) Urinalysis Market, By Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), Application (Disease Screening, Pregnancy and Fertility), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes), Product (Consumables, Systems) – Industry Trends and Forecast to 2030.
Point of Care (POC) Urinalysis Market Analysis and Size
Major factors driving the growth of the market are the rising number of patients suffering from nephropathic disorders worldwide, the shift toward automation in sediment analysis, people's changing lifestyles, and the increasing prevalence of geriatric population are some of the major and impactful factors will likely boost the growth of the point of care (POC) urinalysis market during the forecast period of 2022-2030. On the other hand, increasing applications from emerging economies, as well as the adoption of integrated systems for urinalysis, will generate abundant opportunities, leading to the growth of the point of care (POC) urinalysis market during the forecast period.
Data Bridge Market Research analyses that the point of care (POC) urinalysis market which was USD 1.5 billion in 2022, is expected to reach USD 2.58 billion by 2030, at a CAGR of 7% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Point of Care (POC) Urinalysis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), Application (Disease Screening, Pregnancy and Fertility), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes), Product (Consumables, Systems)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Siemens Healthcare Private Limited (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher (U.S), Sekisui Diagnostics (U.S.), Trinity Biotech (Ireland), bioMérieux (France), EKF Diagnostics (Germany), AccuBioTech Co., Ltd. (China), Instrumentation Laboratory (U.S.), Beckman Coulter, Inc. (U.S.), PTS Diagnostics (U.S.), Nova Biomedical (U.S.), Chembio Diagnostics, Inc. (U.S.), Quidel Corporation (U.S) and Sienco, Inc (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Global Point of Care (POC) Urinalysis Market Dynamics
Drivers
- Increase in age-associated diseases
The ageing population in both developed and developing nations will benefit the market for urinalysis. The prevalence of age-related illnesses such diabetes, liver, and kidney disorders is anticipated to rise dramatically as the senior population overgrows in the forecast period. The growing number of prescriptions for tests like creatinine, albumin, glucose, ketones, and bilirubin among others is due to the diagnosis and treatment of such conditions. Since urinalysis is used to perform these tests, this market is anticipated to benefit.
- Rising need for routine health check-ups
The market is growing as a result of the adaption of point-of-care diagnostics and the increased incidence of chronic diseases. Additionally, the desk-bound lifestyle of working people causes a general lack of good health among the populace in many areas, which promotes the demand for better diagnostics, including urinalysis. Therefore, the growing need for routine health checks is a key factor in the market's expansion.
Opportunities
- Benefits related with OTC-based test
The point of care testing market for OTC tests is expected to develop at a 7.1% CAGR owing to an increase in OTC testing such as pregnancy tests and blood glucose tests that deliver results in a matter of seconds. These examinations do not necessitate the use of a skilled specialist and may be performed by individuals themselves, propelling the industry forward. For instance, The First Response kit is a rapid pregnancy test that gives you a result in 60 seconds. Accu-Chek active blood glucose meter kits also provide readings in 5 seconds, increasing market demand.
Restraints/Challenges
- Unfavorable reimbursement scenario
The obtainability of refurbished instruments, which provide the same functions as new equipment at a reduced price, presents a threat to the expansion of this sector. Lack of solid regulatory frameworks could lead to an increase in the economy's consumption of second-hand goods.
- High Cost
Factors affecting the urinalysis market from growing are the high equipment cost and stringent government regulations.
This point of care (POC) urinalysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point of care (POC) urinalysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Point of Care (POC) Urinalysis Market
The market will grow significantly in 2022 due to the increasing use of point-of-care tests that can quickly identify COVID-19. Because of the need for quick diagnostic results, point-of-care testing has become an important diagnostic technique. Because of the rapidly increasing number of COVID-19 cases and the growing pressure on governments to improve patient management, rapid antigen testing kits that can be used efficiently in point-of-care settings are in high demand. The rising prevalence of other respiratory disorders around the world, the shift toward decentralized diagnostics, and improved access to point-of-care devices via online platforms are all expected to fuel the market's long-term growth.
Global Point of Care (POC) Urinalysis Market Scope
The point of care (POC) urinalysis market is segmented on the basis of product, test type, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Pregnancy and Fertility Tests
- Biochemical Urinalysis
- Laboratory tests
- Point-of-care tests
- Sediment Urinalysis
Application
- Disease Screening
- Urinary tract infections
- Kidney diseases
- Diabetes
- Liver diseases
- Other disease screening applications
- Pregnancy and Fertility
End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Research Laboratories
- Institutes
Product
- Consumables
- Systems
Point of Care (POC) Urinalysis Market Regional Analysis/Insights
The point of care (POC) urinalysis market is analyzed and market size insights and trends are provided by country, product, test type, application, and end user as referenced above.
The countries covered in the point of care (POC) urinalysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the point of care (POC) urinalysis market due to the growing incidences of nephropathic disorders, the increasing number of healthcare infrastructure, and the prevalence of various manufacturers in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing demand of advanced urine analyzers along with occurrence of large patient population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The point of care (POC) urinalysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point of care (POC) urinalysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care (POC) urinalysis market. The data is available for historic period 2011-2021.
Competitive Landscape and Point of Care (POC) Urinalysis Market Share Analysis
The point of care (POC) urinalysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point of care (POC) urinalysis market.
Some of the major players operating in the point of care (POC) urinalysis market are:
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- BD (U.S.)
- Siemens Healthcare Private Limited (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Danaher (U.S)
- Sekisui Diagnostics (U.S.)
- Trinity Biotech (Ireland)
- bioMérieux (France)
- EKF Diagnostics (Germany)
- AccuBioTech Co., Ltd. (China)
- Instrumentation Laboratory (U.S.)
- Beckman Coulter, Inc. (U.S.)
- PTS Diagnostics (U.S.)
- Nova Biomedical (U.S.)
- Chembio Diagnostics, Inc. (U.S.)
- Quidel Corporation (U.S)
- Sienco, Inc (U.S.)
SKU-